Elevance Health Inc
ELV360.670USD
+1.600+0.45%
Close 12/15, 16:00（ET）Quotes delayed by 15 min
80.08BMarket Cap
14.66P/E TTM
More Details of Elevance Health Inc Company
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
Elevance Health Inc Info
Ticker SymbolELV
Company nameElevance Health Inc
IPO dateOct 30, 2001
CEOBoudreaux (Gail K)
Number of employees103158
Security typeOrdinary Share
Fiscal year-endOct 30
Address220 Virginia Avenue
CityINDIANAPOLIS
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code46204
Phone18003311476
Websitehttps://www.elevancehealth.com/
Ticker SymbolELV
IPO dateOct 30, 2001
CEOBoudreaux (Gail K)
Company Executives of Elevance Health Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.35K
+6.87%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.92K
+13.90%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.79K
+14.35%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
1.69K
+3.99%
Ms. Deanna D. Strable-soethout
Ms. Deanna D. Strable-soethout
Independent Director
Independent Director
1.65K
+57.51%
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Independent Director
Independent Director
639.00
--
Mr. Robert L. Dixon, Jr.
Mr. Robert L. Dixon, Jr.
Independent Director
Independent Director
--
--
Mr. Mark B. Kaye
Mr. Mark B. Kaye
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Ratnakar V. Lavu
Mr. Ratnakar V. Lavu
Executive Vice President and Chief Digital Information Officer
Executive Vice President and Chief Digital Information Officer
--
--
Ms. Gail K. Boudreaux
Ms. Gail K. Boudreaux
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.35K
+6.87%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.92K
+13.90%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.79K
+14.35%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
1.69K
+3.99%
Ms. Deanna D. Strable-soethout
Ms. Deanna D. Strable-soethout
Independent Director
Independent Director
1.65K
+57.51%
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Independent Director
Independent Director
639.00
--
Revenue Breakdown
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Premiums
41.27B
0.00%
Product revenue
6.04B
0.00%
Service fees
2.11B
0.00%
Reconciliation
355.00M
0.00%
Operating revenue - affliated
0.00
0.00%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Premiums
41.27B
0.00%
Product revenue
6.04B
0.00%
Service fees
2.11B
0.00%
Reconciliation
355.00M
0.00%
Operating revenue - affliated
0.00
0.00%
Shareholding Stats
Updated: Tue, Nov 18
Updated: Tue, Nov 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
10.30%
BlackRock Institutional Trust Company, N.A.
5.31%
State Street Investment Management (US)
4.66%
Wellington Management Company, LLP
2.98%
Sanders Capital, LLC
2.60%
Other
74.16%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
10.30%
BlackRock Institutional Trust Company, N.A.
5.31%
State Street Investment Management (US)
4.66%
Wellington Management Company, LLP
2.98%
Sanders Capital, LLC
2.60%
Other
74.16%
Shareholder Types
Shareholders
Proportion
Investment Advisor
49.97%
Investment Advisor/Hedge Fund
30.87%
Pension Fund
2.77%
Bank and Trust
2.31%
Hedge Fund
2.17%
Research Firm
2.06%
Sovereign Wealth Fund
1.41%
Family Office
0.27%
Family Office
0.27%
Other
7.92%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
3063
205.92M
97.95%
+22.74K
2025Q3
3138
205.95M
97.05%
-3.45M
2025Q2
3116
209.73M
96.68%
-566.57K
2025Q1
3115
208.90M
96.86%
-10.38M
2024Q4
3105
212.00M
93.76%
+298.05K
2024Q3
2993
212.22M
94.67%
-2.15M
2024Q2
2959
214.26M
94.25%
+1.04M
2024Q1
2925
213.00M
94.22%
-6.19M
2023Q4
2869
213.96M
93.90%
-1.80M
2023Q3
2746
215.71M
93.86%
-2.17M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
22.75M
10.1%
-140.75K
-0.61%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
11.62M
5.16%
-183.35K
-1.55%
Jun 30, 2025
State Street Investment Management (US)
10.57M
4.69%
-78.72K
-0.74%
Jun 30, 2025
Wellington Management Company, LLP
6.32M
2.81%
+523.40K
+9.03%
Jun 30, 2025
Sanders Capital, LLC
5.83M
2.59%
+1.15M
+24.66%
Jun 30, 2025
T. Rowe Price Associates, Inc.
7.75M
3.44%
-1.01M
-11.48%
Jun 30, 2025
Geode Capital Management, L.L.C.
5.09M
2.26%
-72.83K
-1.41%
Jun 30, 2025
Artisan Partners Limited Partnership
3.68M
1.63%
+324.40K
+9.68%
Jun 30, 2025
First Eagle Investment Management, L.L.C.
3.20M
1.42%
-41.22K
-1.27%
Jun 30, 2025
Harris Associates L.P.
2.29M
1.02%
+7.41K
+0.32%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares U.S. Healthcare Providers ETF
4.43%
Monarch Dividend Plus Index ETF
3.25%
John Hancock Fundamental All Cap Core ETF
2.45%
GMO US Quality ETF
2.35%
VictoryShares Free Cash Flow ETF
2.32%
Bushido Capital US Equity ETF
2.2%
State Street SPDR S&P Health Care Services ETF
2.11%
First Eagle Global Equity ETF
2.03%
First Trust Total US Market AlphaDEX ETF
1.75%
First Trust Health Care Alphadex Fund
1.71%
View more
iShares U.S. Healthcare Providers ETF
Proportion4.43%
Monarch Dividend Plus Index ETF
Proportion3.25%
John Hancock Fundamental All Cap Core ETF
Proportion2.45%
GMO US Quality ETF
Proportion2.35%
VictoryShares Free Cash Flow ETF
Proportion2.32%
Bushido Capital US Equity ETF
Proportion2.2%
State Street SPDR S&P Health Care Services ETF
Proportion2.11%
First Eagle Global Equity ETF
Proportion2.03%
First Trust Total US Market AlphaDEX ETF
Proportion1.75%
First Trust Health Care Alphadex Fund
Proportion1.71%
Dividend
A total of
6.19B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Oct 15, 2025
ELV.NB Final Cash Dividend of gross USD 1.71 paid on Dec 19, 2025 going ex on Dec 05, 2025
Dec 05, 2025
Dec 19, 2025
Dec 05, 2025
Jul 17, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Sep 25, 2025 going ex on Sep 10, 2025
Sep 10, 2025
Sep 25, 2025
Sep 10, 2025
Apr 22, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Jun 25, 2025 going ex on Jun 10, 2025
Jun 10, 2025
Jun 25, 2025
Jun 10, 2025
Jan 23, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Mar 25, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 25, 2025
Mar 10, 2025
Oct 17, 2024
ELV.NB Final Cash Dividend of gross USD 1.63 paid on Dec 20, 2024 going ex on Dec 05, 2024
Dec 05, 2024
Dec 20, 2024
Dec 05, 2024
Jul 17, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Sep 25, 2024 going ex on Sep 10, 2024
Sep 10, 2024
Sep 25, 2024
Sep 10, 2024
Apr 18, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Jun 25, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 25, 2024
Jun 10, 2024
Jan 26, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Mar 22, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 22, 2024
Mar 07, 2024
Oct 18, 2023
ELV.NB Final Cash Dividend of gross USD 1.48 paid on Dec 21, 2023 going ex on Dec 05, 2023
Dec 06, 2023
Dec 21, 2023
Dec 05, 2023
Jul 19, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Sep 22, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 22, 2023
Sep 07, 2023
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Elevance Health Inc?
The top five shareholders of Elevance Health Inc are:
The Vanguard Group, Inc. holds 22.75M shares, accounting for 10.10% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 11.62M shares, accounting for 5.16% of the total shares.
State Street Investment Management (US) holds 10.57M shares, accounting for 4.69% of the total shares.
Wellington Management Company, LLP holds 6.32M shares, accounting for 2.81% of the total shares.
Sanders Capital, LLC holds 5.83M shares, accounting for 2.59% of the total shares.
The Vanguard Group, Inc. holds 22.75M shares, accounting for 10.10% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 11.62M shares, accounting for 5.16% of the total shares.
State Street Investment Management (US) holds 10.57M shares, accounting for 4.69% of the total shares.
Wellington Management Company, LLP holds 6.32M shares, accounting for 2.81% of the total shares.
Sanders Capital, LLC holds 5.83M shares, accounting for 2.59% of the total shares.
What are the top three shareholder types of Elevance Health Inc?
The top three shareholder types of Elevance Health Inc are:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
How many institutions hold shares of Elevance Health Inc (ELV)?
As of 2025Q4, 3063 institutions hold shares of Elevance Health Inc, with a combined market value of approximately 205.92M, accounting for 97.95% of the total shares. Compared to 2025Q3, institutional shareholding has increased by 0.90%.
What is the biggest source of revenue for Elevance Health Inc?
In FY2025Q2, the Premiums business generated the highest revenue for Elevance Health Inc, amounting to 41.27B and accounting for --% of total revenue.
